Today, a MedTech company, Olympus Corporation (Olympus), announced the launch of VISERA S (for urology, obstetrics, and gynecology), the all-in-one imaging platform with stroboscopy.
With VISERA S, the clinician can switch between white light, NBI (Narrow Band Imaging), and stroboscopy capabilities and use the sharp HD quality visualization to detect, characterize, and treat ENT disease.
The company will first launch VISERA S from September 2024 in Europe and parts of Asia and Oceania. VISERA S will later be introduced in other regions after product registration has been approved by the local regulatory bodies.
It is designed to help improve ENT diagnostic efficiency and patient experience, including NBI (Narrow Band Imaging) technology, and forms part of the expanding Ear, Nose, and Throat (ENT).
VISERA S offers an advanced video diagnosis system that brings NBI to a range of patient settings, from outpatient offices to private practices.
Martijn Koster, Global ENT Business Unit Leader at Olympus, said, “VISERA S brings the power of early, patient-friendly diagnosis to the office, outpatient, and private practice ENT care settings. By listening and innovating around the needs of our customers and their patients, we envision that the variety of diagnostic tools on the VISERA S can potentially diagnose disease earlier in the patient care pathway. The VISERA S will help ENT physicians deliver next-generation diagnostic imaging that advances their efforts to save lives through earlier diagnosis.”
Also Read: MedTech firm Olympus to set up R&D center in Hyderabad in tie-up with HCLTech
